Loading clinical trials...
Loading clinical trials...
Long-term Follow-up of Safety and Efficacy of OnabotulinumtoxinA for Treatment of Sialorrhea in Juvenile Cerebral Palsy
Conditions
Interventions
onaBoNT-A
Locations
1
Egypt
Hatem Shehata
Cairo, Egypt
Start Date
June 30, 2021
Primary Completion Date
May 1, 2022
Completion Date
April 30, 2023
Last Updated
October 27, 2023
NCT07158359
NCT01994109
NCT03747536
NCT02382198
NCT01844648
Lead Sponsor
Cairo University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions